Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$90.12 - $152.23 $719,157 - $1.21 Million
-7,980 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$112.83 - $239.74 $900,383 - $1.91 Million
7,980 New
7,980 $991,000
Q3 2018

Nov 13, 2018

SELL
$189.1 - $282.92 $2.7 Million - $4.04 Million
-14,283 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$123.8 - $192.48 $3.59 Million - $5.58 Million
-28,990 Reduced 66.99%
14,283 $2.66 Million
Q1 2018

May 14, 2018

BUY
$114.22 - $133.22 $1.85 Million - $2.16 Million
16,185 Added 59.75%
43,273 $5.32 Million
Q4 2017

Feb 14, 2018

BUY
$93.4 - $128.74 $1.17 Million - $1.61 Million
12,510 Added 85.81%
27,088 $3.23 Million
Q3 2017

Nov 13, 2017

BUY
$91.08 - $104.49 $1.33 Million - $1.52 Million
14,578
14,578 $1.39 Million

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $220M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Osterweis Capital Management Inc Portfolio

Follow Osterweis Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Osterweis Capital Management Inc with notifications on news.